Cure My Disease

Don't miss your cure!

 Log in / Sign up

Survey aims to uncover what makes lung rehab work for patients

NCT ID NCT06998550

Knowledge-focused Sponsor: Saglik Bilimleri Universitesi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study surveys 384 adults in Türkiye who have completed a pulmonary rehabilitation program for lung conditions like COPD or asthma. Researchers want to learn how satisfied patients are and how the rehab team's structure affects their experience. No new treatment is being tested—this is purely an observational study to gather insights.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could help improve how pulmonary rehab programs are organized to better meet patient needs.
What could go wrong
This is an observational survey, not a treatment trial. It cannot prove what works best, only describe current experiences.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 384 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Group/Cohort 1 (Label): Patient Group Description: Adults with respiratory disease who have completed a PR program and will complete the Patient Satisfaction Questionnaire. Group/Cohort 2 (Label): Program Coordinator Group Description: Healthcare professionals responsible for PR program coordination who will complete the Institutional Survey Form about organizational and team structures.

Ages

18 to 80 years

Sex

Anyone

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Patient Inclusion Criteria: * Age ≥18 years * Diagnosed with a respiratory condition (e.g., COPD, interstitial lung disease, asthma, bronchiectasis, etc.) * Completed a structured PR program (minimum duration and frequency as defined by national guidelines or center-specific protocols) * Willing and able to complete the online Patient Satisfaction Questionnaire * Able to provide informed consent Patient Exclusion Criteria: * Ongoing participation in a PR program (only completed cases will be included) * Inability to complete the questionnaire due to cognitive or language barriers without a caregiver Coordinator Inclusion Criteria: * Officially designated as the PR program coordinator or responsible team member * Affiliated with a healthcare institution (public, university-affiliated, or private) in Türkiye that provides PR services * Willing to complete the Institutional Survey Form regarding team structure, service delivery, and organizational characteristics * Authorized by the institution to provide structural data related to the PR unit Coordinator Exclusion Criteria: * PR services provided on an informal or ad-hoc basis without a designated team or structure * Institutions not offering a structured PR program

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma bronchiectasis chronic obstructive pulmonary disease interstitial lung disease lung disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pulmonary disease Pulmonary rehabilitation

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Saglik Bilimleri Universitesi

    RECRUITING

    Istanbul, Üsküdar, 34668, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.